Cargando…

The Strategies for Treating “Alzheimer’s Disease”: Insulin Signaling May Be a Feasible Target

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by senile plaques formed by amyloid-beta (Aβ) extracellularly and neurofibrillary tangles (NFTs) formed by hyperphosphorylated tau protein intracellularly. Apart from these two features, insulin deficiency and insulin resistance...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Guanying, Yao, Jinyi, Liu, Qiong, Li, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777526/ https://www.ncbi.nlm.nih.gov/pubmed/36547082 http://dx.doi.org/10.3390/cimb44120421

Ejemplares similares

The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD
por: Yao, Jinyi, et al.
Publicado: (2023)

Alzheimer’s Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound
por: He, Zhijun, et al.
Publicado: (2021)

Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer’s Disease
por: Woodfield, Amy, et al.
Publicado: (2022)

Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
por: Nowell, Joseph, et al.
Publicado: (2022)

Changes in insulin and insulin signaling in Alzheimer’s disease: cause or consequence?
por: Stanley, Molly, et al.
Publicado: (2016)

Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer’s Disease
por: Kang, You Jung, et al.
Publicado: (2020)

Aberrant insulin signaling in Alzheimer's disease: current knowledge
por: Bedse, Gaurav, et al.
Publicado: (2015)

Targeting Neuroinflammation to Treat Alzheimer’s Disease
por: Ardura-Fabregat, A., et al.
Publicado: (2017)

The Role of Insulin Signaling in Hippocampal-Related Diseases: A Focus on Alzheimer’s Disease
por: Liu, Qi, et al.
Publicado: (2022)

Insulin and Insulin Resistance in Alzheimer’s Disease
por: Sędzikowska, Aleksandra, et al.
Publicado: (2021)

Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease
por: de la Monte, Suzanne M
Publicado: (2012)

Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease
por: Onyango, Isaac G., et al.
Publicado: (2021)

The Function of Selenium in Central Nervous System: Lessons from MsrB1 Knockout Mouse Models
por: Shi, Tengrui, et al.
Publicado: (2021)

Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions
por: Schiöth, Helgi B., et al.
Publicado: (2011)

Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer’s Disease
por: Hölscher, Christian
Publicado: (2019)

Insulin Resistance in Alzheimer's Disease
por: Ferreira, Laís S. S., et al.
Publicado: (2018)

Intranasal Insulin for Alzheimer’s Disease
por: Hallschmid, Manfred
Publicado: (2021)

Insulin resistance in the brain: A new therapeutic target for Alzheimer's disease
por: Umegaki, Hiroyuki
Publicado: (2013)

Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease
por: Gong, Cheng-Xin, et al.
Publicado: (2022)

Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease
por: Han, Sun-Ho, et al.
Publicado: (2014)

Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
por: Calvo-Rodriguez, Maria, et al.
Publicado: (2020)

How Can Insulin Resistance Cause Alzheimer’s Disease?
por: Yoon, Ji Hye, et al.
Publicado: (2023)

Phosphoproteomic Profiling of Selenate-Treated Alzheimer's Disease Model Cells
por: Chen, Ping, et al.
Publicado: (2014)

TMEM16F may be a new therapeutic target for Alzheimer’s disease
por: Cui, Zhi-Qiang, et al.
Publicado: (2022)

Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer’s Disease
por: Arab, L, et al.
Publicado: (2011)

Network pharmacology reveals that Berberine may function against Alzheimer’s disease via the AKT signaling pathway
por: Wei, Wei, et al.
Publicado: (2023)

The Link Between Tau and Insulin Signaling: Implications for Alzheimer’s Disease and Other Tauopathies
por: Gonçalves, Rafaella Araujo, et al.
Publicado: (2019)

Curcumin Ameliorates the Impaired Insulin Signaling Involved in the Pathogenesis of Alzheimer’s Disease in Rats
por: Das, Tushar Kanti, et al.
Publicado: (2019)

Screening strategies to identify HSP70 modulators to treat Alzheimer’s disease
por: Repalli, Jayanthi, et al.
Publicado: (2015)

Fecal microbiota transplantation: a novel strategy for treating Alzheimer’s disease
por: Xiang, Wu, et al.
Publicado: (2023)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease
por: Vinuesa, Angeles, et al.
Publicado: (2021)

Brain insulin resistance in Alzheimer’s disease
Publicado: (2012)

The Rationale for Insulin Therapy in Alzheimer’s Disease
por: Ribarič, Samo
Publicado: (2016)

Dietary Polyphenols: A Multifactorial Strategy to Target Alzheimer’s Disease
por: Dhakal, Sudip, et al.
Publicado: (2019)

Dendrimers in Alzheimer’s Disease: Recent Approaches in Multi-Targeting Strategies
por: Arbez-Gindre, Cécile, et al.
Publicado: (2023)

Type 2 Diabetes Mellitus and Alzheimer’s Disease: Role of Insulin Signalling and Therapeutic Implications
por: Tumminia, Andrea, et al.
Publicado: (2018)

Involvement of Insulin Signaling Disturbances in Bisphenol A-Induced Alzheimer’s Disease-like Neurotoxicity
por: Wang, Tingwei, et al.
Publicado: (2017)

Targeting psychologic stress signaling pathways in Alzheimer’s disease
por: Futch, Hunter S., et al.
Publicado: (2017)

Magnesium may be an effective therapy for Alzheimer’s disease
por: Lei, Dao-Yun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cq1b9c9qr9nodm8avmcgl83k9c